Introduction
Lithium has been in use over half a century in the treatment of bipolar disorder as a traditional mood stabilizer. It is effective in the treatment of acute mania and for the long-term maintenance of mood and as prophylaxis; in comparison, evidence for its efficacy in depression is modest. However, lithium
Interference in Serum Lithium Estimation by Silica Clot Activator and
Silicone Surfactant in ISE Principle: a Cross-Sectional Study serum Lithium concentration assay for more than a decade by ISE (Ion Selective Electrode) principle using USA manufactured world class analyzer NOVA-4 with no previous report of error. Besides, NOVA-4 is also in use for serum electrolyte estimation. So, a high degree of quality control is always carefully ensured by 2 hourly autocalibrations. If the analyzer is uncalibrated for any of its performing parameters, that parameter cannot be estimated or reported. Moreover the Department's confidence was further strengthened by its excellent 'Internal Quality Control' as well as by the proven performance in 'External Quality control' under UK (United Kingdom) RANDOX. Definitely QC is the ultimate determining strength for any laboratory. So, the Department took the observation seriously and worked over it. This time the Department asked for another sample from that patient. Calibrator and control were run with special attention. Patient's sample was measured in replicate for thrice. All three results were found to be high beyond the therapeutic range though the patient omitted the drugs. The Department then collected specimens at AFIP from 'the volunteers of AFIP' (technicians and pathologists), who never took Tab Lithium. The results of the volunteers were below analyzer assay range i.e. undetectable, indicating that the analyzer performance was well. So, it was obvious for that specific patient error was somewhere, but where? No clue to reach the light, making the biochemist confused what to do? Then a clue came from a journal 1 that positive interference occurs with the ionselective electrode based determination of lithium when blood is collected in a 10-ml plain red-top plastic vacutainer plus tube containing silica clot activator and silicone surfactant. AFIP Chemical Pathology Department, then considered collection tube might be a possible source of interference because all the collection tubes were from that hospital and afterwards sent in eppendrofs to AFIP. This time the Department asked some empty collection tubes from that hospital and noticed that the tubes were 'vacutainer plus tubes' containing 'silica clot activator and silicone surfactant; in contrast tubes in use at AFIP are vacutainer tubes with 'no additive'. The present study was designed to demonstrate the interference due to specimen collection tube in serum lithium estimation by ISE. Then serum sample of the same patient in eppendrof was sent to AFIP and to three other reputed laboratories on 24th may and results of Serum Lithium concentration were in AFIP: 1.7 mmol/l, in the 1st lab: 0.4 mmol/l, in the 2nd lab: 0.6 mmol/l and in the 3rd lab: 0.4 mmol/l against the same therapeutic range of 0.6-1.2 mmol/l. So, it was obvious that the Serum Lithium result of AFIP was quite higher than other laboratories. This time that hospital willfully sent a serum sample of one of their physicians in eppendorf, who was never known to take Tab Lithium till 27th May 2016. As before, AFIP Serum Lithium concentration was higher, found in 'warning limit' of 1.5 mmol/l. So, they notified AFIP Chemical Pathology Department about the fact. At first, the Department was in a state of shock. But, the strength was that AFIP had been performing Again, lithium concentration of 10 individuals, who used to take Tab Lithium in blood collected in 'plain tubes' and measured by ISE using Nova-4 had mean concentration of 0.57±0.22
Materials and Methods
In this cross-sectional study, 40 subjects were selected, among them 30 healthy volunteers, who never took Tab Lithium and 10 patients used to take Tab Lithium for bipolar mood disorder and were referred to AFIP for serum lithium estimation. The study was carried out from May 2015 to July 2015 at Chemical Pathology Department, AFIP. Blood specimens were collected from the study subjects in both 'plain red-top plastic vacutainer tubes without additive' (plain tube) as well as 'plain red-top plastic vacutainer plus tubes containing silica clot activator and silicone surfactant' (tube with clot activator). Informed consents were obtained from all the study subjects.
Serum lithium were estimated in blood collected in both types of tubes with and without additives by Ion-Selective Electrodes (ISEs) using NOVA-4, USA. It is based on a special-purpose, potentiometric electrode consisting of a membrane selectively permeable to a single ionic species i.e. lithium. The potential produced at the membranesample solution interface is proportional to the logarithm of the lithium activity or concentration. Besides, serum lithium was also measured in both groups of tubes by colorimetric method using Dade Dimension, Siemens in which lithium present in the sample reacts with porphyrin at an alkaline pH, resulting in a change in absorbance which is directly proportional to the concentration to the lithium in the sample.
Results
Serum lithium concentration of lithium-free normal volunteers in case of blood collected in 'plain tubes' consistently gave results below analytical assay range i.e. undetectable by the ISE analyzer. Whereas, for the same, blood collected in 'tubes with clot activator' the serum lithium measured by ISE found mean concentration to be 1.78±0.40 mmol/l, with minimum 1.18 mmol/l and maximum 2.71 mmol/l, though their serum actually should be undetectable for lithium.
Comparison of serum lithium concentration results in these two groups found statistically highly significant (p<0.0001) with 95% confidence interval. When identical sera in both types of tubes with and without clot activator were estimated for lithium concentration by colorimetric method using 'Dade Dimension' then all the results were below analytical assay range i.e. undetectable for both types of tubes. (Table 1 (Table  II) . 7 . In case of 'vacutainer plus tubes' the silica clot activator and silicone surfactant appears to interact with lithium ion-specific analyzer membranes, which increase the measured voltage/potential and falsely elevate serum lithium ion concentration 7, 8 .
In this study, the result of mean lithium concentration of serum collected in tubes without additive are decreased by 79.6% than serum collected in tubes with silica clot activator and silicone surfactant. Maureen Sampson et al 7 , in his study showed lithium concentrations in serum without silica clot activator (SCA) are decreased by 20%. Such a greater decrease in lithium concentration in tubes without additive in our study may be due to volume of blood collected in the vacutianer tubes, as blood volume is inversely related to the apparent Lithium concentration 7 .
Vacutainer tubes supplied by different manufacturers vary in the materials and additives that can potentially affect the test performance. Silicone surfactant coated tubes have been shown to interfere with ion-specific electrode measurement of not only lithium but also of ionized magnesium 7, 8 through interaction with ionspecific electrode membranes leading to increase in the measured voltage. In addition, water-soluble silicone polymer coatings in separator tubes can physically mask antibodies and alter avidin-biotin binding reactions in immunoradiometric assays 8 .
Laboratories other than AFIP, Chemical Pathology Department performed serum lithium estimation by a colorimetric method readily adapted to automated clinical chemistry analyzers (Dade Dimension, Siemens). In this method lithium present in the sample reacts with a substituted porphyrin compound at an alkaline pH, resulting in a change in color which is directly proportional to the concentration of
